Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis

Br J Surg. 2021 May 27;108(5):e211. doi: 10.1093/bjs/znab055.

Kun-Ming Rau^{1

2}, Chao-Sung Chang^{1

3}, Sung-Nan Pei^{1

4}, Meng-Che Hsieh^{1

2}, Yu-Fen Tsai^{1

4}, Chong-Chi Chiu^{5

6}

¹ Department of Hematology & Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan.
² College of Medicine, I-Shou University, Kaohsiung, Taiwan.
³ School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
⁴ School of Chinese Medicine for Post Baccalaureate, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
⁵ Department of General Surgery, E-Da Cancer Hospital, Kaohsiung, Taiwan.
⁶ School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.

No abstract available

Publication types